COFEPRIS-2021-0094-V094

Type II variation for application COFEPRIS-2021-0094. Type II variation: New Dosage Strength for Neprilozone — critical change

Variation Number
COFEPRIS-2021-0094-V094
Type
Type II
Application
COFEPRIS-2021-0094
Change
CHG-2023-0094
Status
Draft
Fee
€42,375
Submitted
2022-08-06
Approved
—
Description

Type II variation: New Dosage Strength for Neprilozone — critical change